Exact Sciences to Participate in December Investor Conferences

Exact Sciences (Nasdaq: EXAS), a cancer screening and diagnostic tests provider, has announced its management's participation in two upcoming investor conferences in Miami.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Tags

conferences

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

11/26/2024 - 06:00 AM

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

Citi Global Healthcare Conference, Miami
Fireside chat on Tuesday, December 3, 2024 at 8:45 a.m. ET

Evercore HealthCONx Conference, Miami
Fireside chat on Wednesday, December 4, 2024 at 7:30 a.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.